-
Posted by
Two Blokes Apr 15 -
Filed in
Stock
-
3 views
SAN FRANCISCO, CA / ACCESS Newswire / April 15, 2025 / Zynex, Inc. (NASDAQ:ZYXI), the Denver-based medical technology firm, is facing a deepening vortex of financial, regulatory and legal challenges, with RBC Capital Markets reportedly further reducing its outlook on the company's stock. The company faces added pressure from a recently filed securities class action lawsuit, alleging the company made false and misleading statements regarding its revenue recognition practices and its relationship with Tricare, a major payer now temporarily suspending payments.
